摘要
[目的]探讨卡莫氟配合放射治疗贲门癌的增敏价值。[方法]对30例贲门癌患者采用常规放疗合并口服卡莫氟治疗。[结果]1、2、3年生存率分别为76.7%、46.7%及23.3% ,治疗后血象无明显变化 ,腹泻、恶心呕吐不严重。[结论]口服卡莫氟对贲门癌放疗有增敏作用 ,可提高患者生存率和生活质量。
To probe enhanced sensitivity value of treating cardiac cancer with the method of radiotherapy combined with Carmofur.Thirty cases of cardiac cancer patients were treated by means of conventional radiotherapy with Carmofur.The survival rate of 1 ,2 ,3 year was 76.7%,46.7%and 23.3% respectively.Hemogram did not change significantly.No severe diarrhoea,nausea and vomiting were found after treatment.[Conclusion]Carmofur can enhance radiosensitivity in treatment for cardiac cancer by means of radiotherapy,and can improve the survival rate and the patients quality of life.
出处
《中国肿瘤》
CAS
2001年第8期491-492,共2页
China Cancer
关键词
贲门肿瘤
放射疗法
卡莫氟
放射增敏
预后
cardiac neoplasms
radiotherapy
Carmofur
radiosensitivity
prognosis
